2010
Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?
Bauch CT, Li M, Chapman G, Galvani AP. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? The Lancet Infectious Diseases 2010, 10: 133-137. PMID: 20113982, DOI: 10.1016/s1473-3099(10)70004-9.Peer-Reviewed Original ResearchConceptsCervical cancerVaccinated womenVaccine coverageEffective cervical screening programmesHuman papillomavirus vaccinationCervical screening programmeHigh-risk typesIntroduction of vaccinesPapillomavirus vaccinationOncogenic typesCervical screeningOpportunistic screeningScreening programPrevents infectionCancerVaccineIncidenceContinued screeningWomenVaccinationScreeningPopulationDisease incidenceInfection
2008
Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets
Basu S, Chapman GB, Galvani AP. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings Of The National Academy Of Sciences Of The United States Of America 2008, 105: 19018-19023. PMID: 19015536, PMCID: PMC2596236, DOI: 10.1073/pnas.0808114105.Peer-Reviewed Original ResearchConceptsHPV vaccinationCervical cancerVaccination levelsVaccination targetsCervical cancer prevention programsHuman papillomavirus vaccineVaccine-eligible childrenCancer prevention programsHealth-related utilityVaccine recipientsGenital wartsPapillomavirus vaccineVaccination recommendationsVaccination goalsVaccine risksPrevention programsVaccinationSexual activityCancerCoverage planCost subsidizationSurvey respondentsVaccineEpidemiologyIncidence